Michael T. Constantino - 12 Jun 2025 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director
Signature
/s/ Michael T. Constantino by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
12 Jun 2025
Transactions value $
$0
Form type
4
Filing time
16 Jun 2025, 16:31:09 UTC
Previous filing
08 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Constantino Michael T. Director 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM /s/ Michael T. Constantino by Dale A. Sander as Attorney-in-Fact 16 Jun 2025 0001817285

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Award $0 +80K $0.00 80K 12 Jun 2025 Common Stock 80K $2.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.